Substance Abuse and Mental Health Services Administration, Rockville, Maryland.
National Institute on Drug Abuse, the National Institutes of Health, Bethesda, Maryland.
JAMA. 2015 Oct 13;314(14):1468-78. doi: 10.1001/jama.2015.11859.
Since 1999, the United States has experienced increases in morbidity and mortality associated with nonmedical use of prescription opioids.
To assess national trends in and characteristics of nonmedical prescription opioid use and use disorders and the national trend in related mortality.
DESIGN, SETTING, AND PARTICIPANTS: Prevalence of nonmedical use and use disorders and related risk factors were based on data from 472,200 persons aged 18 through 64 years who participated in the 2003-2013 National Surveys on Drug Use and Health. Mortality was based on the 2003-2013 National Vital Statistics System's Multiple Cause of Death Files.
Prevalence of nonmedical use of prescription opioids.
Nonmedical prescription opioid use and use disorders.
Among adults aged 18 through 64 years, the prevalence of nonmedical use of prescription opioids decreased from 5.4% (95% CI, 5.08%-5.70%) in 2003 to 4.9% (95% CI, 4.58%-5.22%) in 2013 (absolute difference, -0.5%; 95% CI, -0.11% to -0.89%), but the prevalence of prescription opioid use disorders increased from 0.6% (95% CI, 0.54%-0.76%) in 2003 to 0.9% (95% CI, 0.75%-1.01%) in 2013 (absolute difference, 0.3%; 95% CI, 0.03%-0.43%). The 12-month prevalence of high-frequency use (≥200 days) also increased from 0.3% (95% CI, 0.19%-0.35%) in 2003 to 0.4% (95% CI, 0.31%-0.48%) in 2013 (absolute difference, 0.1%; 95% CI, 0.01%-0.29%). Mortality assessed by drug overdose death rates involving prescription opioids increased from 4.5 per 100,000 (95% CI, 4.42-4.61) in 2003 to 7.8 per 100,000 (95% CI, 7.64-7.89) in 2013 (absolute difference, 3.3; 95% CI, 3.09-3.41) among adults aged 18 through 64 years. The mean number of days of nonmedical use of prescription opioids increased from 2.1 (95% CI, 1.83-2.37) in 2003 to 2.6 (95% CI, 2.27-2.85) in 2013 (absolute difference, 0.5, 95% CI, 0.05-0.86). The model-adjusted prevalence of having prescription opioid use disorders among nonmedical users increased to 15.7% (95% CI, 13.87%-17.67%) in 2010, 16.1% (95% CI, 14.36%-17.99%) in 2011, 17.0% (95% CI, 15.07%-19.12%) in 2012, and 16.9% (95% CI, 14.95%-19.03%) in 2013 from 12.7% (95% CI, 11.04%-14.53%) in 2003.
During the 2003-2013 years, among adults aged 18 through 64 years, the percentage of nonmedical use of prescription opioids decreased. In contrast, the prevalence of prescription opioid use disorders, frequency of use, and related mortality increased.
自 1999 年以来,美国因非医疗用途使用处方类阿片而导致的发病率和死亡率有所上升。
评估非医疗用途使用处方类阿片和使用障碍的全国性趋势和特征,以及相关死亡率的全国性趋势。
设计、地点和参与者:基于 472,200 名 18 至 64 岁的参与 2003-2013 年国家药物使用和健康调查的人的数据,评估了非医疗使用和使用障碍以及相关风险因素的流行率。死亡率基于 2003-2013 年国家生命统计系统的多原因死亡档案。
处方类阿片非医疗使用的流行率。
非医疗使用处方类阿片和使用障碍。
在 18 至 64 岁的成年人中,非医疗使用处方类阿片的流行率从 2003 年的 5.4%(95%CI,5.08%-5.70%)下降到 2013 年的 4.9%(95%CI,4.58%-5.22%)(绝对差异,-0.5%;95%CI,-0.11%至-0.89%),但处方类阿片使用障碍的流行率从 2003 年的 0.6%(95%CI,0.54%-0.76%)上升到 2013 年的 0.9%(95%CI,0.75%-1.01%)(绝对差异,0.3%;95%CI,0.03%-0.43%)。高频使用(≥200 天)的 12 个月流行率也从 2003 年的 0.3%(95%CI,0.19%-0.35%)上升到 2013 年的 0.4%(95%CI,0.31%-0.48%)(绝对差异,0.1%;95%CI,0.01%-0.29%)。涉及处方类阿片的药物过量死亡率评估的死亡率从 2003 年的每 10 万人 4.5 例(95%CI,4.42-4.61)上升到 2013 年的每 10 万人 7.8 例(95%CI,7.64-7.89)(绝对差异,3.3;95%CI,3.09-3.41),在 18 至 64 岁的成年人中。非医疗使用处方类阿片的平均天数从 2003 年的 2.1 天(95%CI,1.83-2.37)增加到 2013 年的 2.6 天(95%CI,2.27-2.85)(绝对差异,0.5,95%CI,0.05-0.86)。非使用者中患有处方类阿片使用障碍的模型调整后流行率从 2010 年的 15.7%(95%CI,13.87%-17.67%)增加到 2011 年的 16.1%(95%CI,14.36%-17.99%),2012 年的 17.0%(95%CI,15.07%-19.12%),2013 年的 16.9%(95%CI,14.95%-19.03%)从 2003 年的 12.7%(95%CI,11.04%-14.53%)。
在 2003-2013 年期间,在 18 至 64 岁的成年人中,处方类阿片非医疗使用的比例有所下降。相比之下,处方类阿片使用障碍、使用频率和相关死亡率有所上升。